|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2004-9-7
|
|
pubmed:abstractText |
The aim of this study was to explore differences in the cytokine profile among de novo kidney transplant recipients treated with either Rapamycin (Rapa) + cyclosporine (CsA) + prednisone (P) or CsA + azathioprine (Aza) + P.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0041-1345
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
36
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1661-3
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:15350444-Adult,
pubmed-meshheading:15350444-Azathioprine,
pubmed-meshheading:15350444-Cyclosporine,
pubmed-meshheading:15350444-Cytokines,
pubmed-meshheading:15350444-Drug Therapy, Combination,
pubmed-meshheading:15350444-Humans,
pubmed-meshheading:15350444-Immunosuppressive Agents,
pubmed-meshheading:15350444-Interferon-gamma,
pubmed-meshheading:15350444-Interleukin-10,
pubmed-meshheading:15350444-Interleukin-2,
pubmed-meshheading:15350444-Kidney Transplantation,
pubmed-meshheading:15350444-Prednisone,
pubmed-meshheading:15350444-Sirolimus,
pubmed-meshheading:15350444-Transforming Growth Factor beta
|
|
pubmed:articleTitle |
Effect of rapamycin on cytokine profile in kidney transplant recipients treated with triple drug therapy.
|
|
pubmed:affiliation |
Departments of Nephrology and Mineral Metabolism, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
